FIELD: medicine; pharmaceutics.
SUBSTANCE: invention relates to the use of a compound selected from the group consisting of triamterene and nolatrexed or a pharmaceutically acceptable salt thereof, as well as a combination of said compounds with other active ingredients, selected from sulphopride, hydrastinine, bufuralol, valganciclovir, ricobendazole, albendazole, valacyclovir, minoxidil, loxoribine, sapropterin, sepiapterin, oxytriptan, pyrimethamine, pegvaliase or a pharmaceutically acceptable salt thereof, in the treatment and/or prevention of phenylketonuria and for the preparation of a drug for the treatment and/or prevention of phenylketonuria.
EFFECT: use of the group of inventions makes it possible to effectively treat and/or prevent phenylketonuria.
22 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NUTRITIONAL COMPOSITION FOR IMPROVING CEREBRAL FUNCTION IN PHENYLKETONURIA | 2014 |
|
RU2690660C2 |
| METHODS FOR TREATMENT OF PHENYLKETONURIA | 2019 |
|
RU2788484C2 |
| NUTRITIVE PRODUCT FOR REDUCING PHENYLALANINE LEVELS IN THE PATIENTS WITH PKU | 2016 |
|
RU2740905C2 |
| METHODS AND COMPOSITIONS FOR TREATING PHENYLKETONURIA | 2008 |
|
RU2496489C2 |
| IMPROVED CLEANSING OF POLYSPECIFIC RECEPTORS | 2010 |
|
RU2605924C2 |
| NON-VIRAL DNA VECTORS AND OPTIONS FOR THEIR USE FOR EXPRESSION OF THERAPEUTIC AGENT BASED ON PHENYLALANINE HYDROXYLASE (PAH) | 2020 |
|
RU2814137C2 |
| METHODS OF TREATING VIRUS-ASSOCIATED FORMS OF CANCER WITH HISTONE DEACETYLASE INHIBITORS | 2020 |
|
RU2819782C2 |
| COMPOSITIONS OF PROKARYOTIC PHENYLALANINE-AMMONIA-LYASE AND METHOD OF CANCER TREATMENT WITH APPLICATION OF SUCH COMPOSITIONS | 2008 |
|
RU2553343C2 |
| COMPOSITIONS OF TETRAHYDROBIOPTERINE AND METHODS OF ITS QUANTITATIVE ASSESSMENT | 2008 |
|
RU2486899C2 |
| COMBINATION THERAPY OF PULMONARY HYPERTENSION | 2016 |
|
RU2780758C2 |
